Myopia Management at I-Vision Optometrists

Myopia, commonly known as near-sightedness, is an increasingly prevalent condition affecting both children and adults globally. At I-Vision Optometrists, we specialise in advanced myopia management strategies to slow the progression of myopia, particularly in younger patients. Our approach integrates the latest in lens technology and customised treatment plans to provide effective myopia control.

Understanding Myopia

Myopia occurs when the eyeball elongates excessively, causing light to focus in front of the retina rather than directly on it. This results in blurred distance vision. Factors contributing to its increase include family history, high levels of screen time, limited outdoor activities, and poor lighting conditions. Early intervention is crucial to manage this condition effectively and to help prevent potential future eye health problems.

Cutting-Edge Treatments for Myopia

We offer several innovative treatments to manage myopia:

MIYOSMART Lenses by HOYA with DIMS Technology

These lenses have shown to slow the progression of myopia in children by about 50%. They use a special diffractive optical design to provide clear vision and manage eye growth.

eye refraction assessment

MiSight Soft Lenses

These contact lenses are specifically designed for children and aim to slow myopia progression significantly.

eye refraction assessment

Orthokeratology (Ortho-K) Lenses

Worn overnight, these lenses gently reshape the cornea, temporarily correcting myopia so glasses and contact lenses aren’t needed during the day.

eye refraction assessment

Atropine Eye Drops

Low-dose atropine eye drops have been used to slow the progression of myopia in some children.

Our treatments are backed by the latest research and technology, ensuring safe and effective myopia management.

Customised Myopia Management Plans

Each patient receives a personalised management plan based on their specific needs and lifestyle. During the initial consultation, our optometrists assess the severity of myopia and discuss the most suitable options. We monitor progress closely and adjust treatments as necessary to achieve the best possible outcomes.
eye refraction assessment

Commitment to Education and Awareness

We believe in empowering our patients and their families through education about myopia. Understanding the causes, risks, and management options is key to effective treatment. Educating patients and parents alike is part of our commitment to community health.

Due for an eye test?

Don’t wait until you notice a problem with your vision. Book an appointment with our expert team at I-Vision Optometrists in Perth to ensure your eyes are in the best possible health. Call us or book online to schedule your next visit. We also accept walk-ins.

Frequently Asked Questions (FAQs) about Myopia Management

What causes myopia to progress in children?
Factors include genetics, excessive close-up tasks like reading or screen use, and not enough time spent outdoors.
How effective are the myopia management treatments?
Treatments like MIYOSMART lenses and Ortho-K have been clinically proven to slow the progression of myopia by up to 50% in some cases.
At what age should myopia management start?
Early intervention is key. Management can begin as soon as myopia is diagnosed, often in early childhood.
Are there any side effects to myopia management treatments?
Treatments like atropine eye drops and Ortho-K are generally very safe but can have minor side effects. We provide full information during consultations.
How often should my child's vision be checked if they are undergoing myopia management?
Regular follow-ups, typically every 3 or 6 to 12 months, are crucial to monitor the effectiveness of the treatment and make adjustments as needed. The exact recall schedule will be determined by our optometrists in your consultation.

For further detailed information on myopia and its management, reputable sources such as the Better Health Channel, and the Myopia Profile, offer extensive educational materials and updates on recent research.